Laninamivir

Usual Route of Administration

Oral inhalation

Dose Adjustment on Renal Impairmant

Minimal absorption of orally inhaled drug suggests no dose adjustment.

Consult product monograph for updated information in relation to drug exposure based on type of delivery device.

Adverse Events

More Common

  • Diarrhea

  • Vomiting

  • Nausea

Less Common

  • Dizziness

  • Syncope with inhalation

  • Reports of abnormal behaviour similar to oseltamivir and peramivir (limited experience to date).

Comments

Long-acting

Approved in Japan since 2010

Not yet approved in North America.